DE2059429C2 - Verfahren zur Herstellung von Nucleosiddiphosphatestern - Google Patents

Verfahren zur Herstellung von Nucleosiddiphosphatestern

Info

Publication number
DE2059429C2
DE2059429C2 DE2059429A DE2059429A DE2059429C2 DE 2059429 C2 DE2059429 C2 DE 2059429C2 DE 2059429 A DE2059429 A DE 2059429A DE 2059429 A DE2059429 A DE 2059429A DE 2059429 C2 DE2059429 C2 DE 2059429C2
Authority
DE
Germany
Prior art keywords
nucleoside
phosphoric acid
solution
phosphate
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2059429A
Other languages
German (de)
English (en)
Other versions
DE2059429A1 (de
Inventor
Hans-Ulrich Prof. Dr.rer.nat. 8132 Tutzing Bergmeyer
Erich 8120 Weilheim Haid
Michael Dr.phil. 8132 Tutzing Nelböck-Hochstetter
Günter Dr.rer.nat. 8130 Starnberg Weimann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE2059429A priority Critical patent/DE2059429C2/de
Priority to JP323971A priority patent/JPS5335953B1/ja
Priority to ES395861A priority patent/ES395861A1/es
Priority to IL37977A priority patent/IL37977A/xx
Priority to NLAANVRAGE7114920,A priority patent/NL171064C/xx
Priority to US00202573A priority patent/US3787392A/en
Priority to GB5557571A priority patent/GB1305539A/en
Priority to HUBO1333A priority patent/HU163083B/hu
Priority to SU1721408A priority patent/SU407449A1/ru
Priority to FR7143358A priority patent/FR2117325A5/fr
Publication of DE2059429A1 publication Critical patent/DE2059429A1/de
Application granted granted Critical
Publication of DE2059429C2 publication Critical patent/DE2059429C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
DE2059429A 1970-12-02 1970-12-02 Verfahren zur Herstellung von Nucleosiddiphosphatestern Expired DE2059429C2 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE2059429A DE2059429C2 (de) 1970-12-02 1970-12-02 Verfahren zur Herstellung von Nucleosiddiphosphatestern
JP323971A JPS5335953B1 (cg-RX-API-DMAC10.html) 1970-12-02 1971-01-29
ES395861A ES395861A1 (es) 1970-12-02 1971-10-08 Procedimiento para la preparacion de esteres de nucleosido-difosfato.
IL37977A IL37977A (en) 1970-12-02 1971-10-20 Process for the preparation of nucleoside diphosphate esters
NLAANVRAGE7114920,A NL171064C (nl) 1970-12-02 1971-10-29 Werkwijze ter bereiding van nucleoside-difosfaatesters.
US00202573A US3787392A (en) 1970-12-02 1971-11-26 Process for the preparation of nucleoside diphosphate esters
GB5557571A GB1305539A (cg-RX-API-DMAC10.html) 1970-12-02 1971-11-30
HUBO1333A HU163083B (cg-RX-API-DMAC10.html) 1970-12-02 1971-12-01
SU1721408A SU407449A1 (ru) 1971-12-02 Способ получения сложных эфиров нуклеозиддифосфата
FR7143358A FR2117325A5 (cg-RX-API-DMAC10.html) 1970-12-02 1971-12-02

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2059429A DE2059429C2 (de) 1970-12-02 1970-12-02 Verfahren zur Herstellung von Nucleosiddiphosphatestern

Publications (2)

Publication Number Publication Date
DE2059429A1 DE2059429A1 (de) 1972-06-22
DE2059429C2 true DE2059429C2 (de) 1986-10-23

Family

ID=5789823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2059429A Expired DE2059429C2 (de) 1970-12-02 1970-12-02 Verfahren zur Herstellung von Nucleosiddiphosphatestern

Country Status (9)

Country Link
US (1) US3787392A (cg-RX-API-DMAC10.html)
JP (1) JPS5335953B1 (cg-RX-API-DMAC10.html)
DE (1) DE2059429C2 (cg-RX-API-DMAC10.html)
ES (1) ES395861A1 (cg-RX-API-DMAC10.html)
FR (1) FR2117325A5 (cg-RX-API-DMAC10.html)
GB (1) GB1305539A (cg-RX-API-DMAC10.html)
HU (1) HU163083B (cg-RX-API-DMAC10.html)
IL (1) IL37977A (cg-RX-API-DMAC10.html)
NL (1) NL171064C (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2637598C3 (de) * 1976-08-20 1981-04-02 Boehringer Mannheim Gmbh, 6800 Mannheim Orthorhombisches Monolithiumsalz des β-Nicotinamid-adenindinucleotids und Verfahren zu seiner Herstellung
US4291024A (en) * 1978-04-10 1981-09-22 Turcotte Joseph G Cytotoxic liponucleotide analogs
US5627161A (en) * 1984-12-20 1997-05-06 Memorial Hospital For Cancer And Allied Diseases Method for treating tumors with UDPG
IT1197297B (it) * 1986-09-26 1988-11-30 Vecchi & C Piam Di G Assereto Composizioni farmaceutiche ad attivita' sul sistema nervoso centrale
US5109125A (en) * 1989-04-07 1992-04-28 Du Pont Merck Pharmaceutical Company Process for purifying nucleoside-5'-diphosphates
KR0125779B1 (ko) * 1993-12-04 1997-12-19 김승호 뉴클레오시드 화합물 및 이의 제조방법
TW200741005A (en) * 2005-08-10 2007-11-01 Kyowa Hakko Kogyo Kk A purification method of cytidine diphosphate
EP2820028A4 (en) * 2012-02-28 2015-08-26 Frichem Private Ltd PROCESS FOR THE PREPARATION OF PURE CITICOLINE (CDP-CHOLINE)
CN112521436B (zh) * 2020-12-08 2022-09-16 吉林百年汉克制药有限公司 一种5’-胞苷酸衍生物的制备方法及在胞磷胆碱、胞磷胆碱钠及其注射剂中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321462A (en) * 1963-07-15 1967-05-23 Syntex Corp Process for the preparation of nucleoside polyphosphates
FR1566530A (cg-RX-API-DMAC10.html) * 1967-03-14 1969-05-09
FR1590693A (cg-RX-API-DMAC10.html) * 1967-09-22 1970-04-20
DE2016049C3 (de) * 1970-04-03 1975-09-11 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von Nucleosiddiphosphaten bzw. ihren Estern

Also Published As

Publication number Publication date
ES395861A1 (es) 1973-12-16
NL171064C (nl) 1983-02-01
IL37977A0 (en) 1971-12-29
DE2059429A1 (de) 1972-06-22
NL171064B (nl) 1982-09-01
JPS5335953B1 (cg-RX-API-DMAC10.html) 1978-09-29
FR2117325A5 (cg-RX-API-DMAC10.html) 1972-07-21
HU163083B (cg-RX-API-DMAC10.html) 1973-06-28
SU407449A3 (cg-RX-API-DMAC10.html) 1973-11-21
US3787392A (en) 1974-01-22
IL37977A (en) 1974-03-14
NL7114920A (cg-RX-API-DMAC10.html) 1972-06-06
GB1305539A (cg-RX-API-DMAC10.html) 1973-02-07

Similar Documents

Publication Publication Date Title
US3201389A (en) Method for preparing ribonucleoside-5'-phosphates or their salts from ribonucleosides
EP0369182A1 (de) Tumorhemmende Saccharid-Konjugate
DE2059429C2 (de) Verfahren zur Herstellung von Nucleosiddiphosphatestern
DE1645896B2 (de) Verfahren zur Herstellung von 5'-Ribonucleotiden und 5'Desoxyribonucleotiden
DE2546073A1 (de) Nucleotid-derivate und verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE1620643A1 (de) Verfahren zur Herstellung von neuen Dinucleosidphosphaten
DE1918282C3 (de) Verfahren zur Herstellung von Diestern kondensierter Phosphorsäuren
DE2016049C3 (de) Verfahren zur Herstellung von Nucleosiddiphosphaten bzw. ihren Estern
DE2760351C2 (cg-RX-API-DMAC10.html)
CH515249A (de) Verfahren zur Herstellung von 2',5'- und 3',5'- Dinucleosidphosphaten
EP0364875B1 (de) Riboflavin-4'5'-cyclo-phosphorsäureesterchlorid, dessen Herstellung und Verwendung zur Herstellung von Riboflavin-5'-phosphat (5'-FMN) bzw. dessen Natriumsalz
DE69007775T2 (de) 5'-alkylphosphonylnukleoside als antivirale verbindungen.
DE2308801A1 (de) Verfahren zur herstellung von nucleosid-5'-diphosphat-aethanolaminen
DE2626792A1 (de) Acylderivate von adenosin-5'-monophosphorsaeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE2621470A1 (de) Nucleosidcarbonsaeurenitrile und ihre derivate, und verfahren zu ihrer herstellung
DE2430550C2 (de) Äthanol-Wasser-Solvate von Natriumhexametaphosphatkomplexen des α-6-Desoxy-5-hydroxy-tetracyclin und ein Verfahren zu deren Herstellung
DE2944084A1 (de) 3'-polyphosphate von pyrimidinnucleosiden oder von guanosin und deren salze sowie die verwendung dieser verbindungen zur behandlung von leukaemie
DE2014440C3 (de) Verfahren zur Herstellung von Nucleosid-5'-di- und -5'-triphosphaten
EP0502298A2 (de) Verfahren zur stereoselektiven Herstellung von beta-Fucopyranosylphosphaten und sehr reiner GDP-Fucose
DE1645984B2 (de) Verfahren zur Herstellung von 51-Ribofuranosyl-, 5"-Arabinofuranosyl- und o'-Glucopyranosyl-Nucleotiden
DE4400310A1 (de) Neue Nukleosid-Lipid-Addukte, ihre Herstellung und ihre pharmazeutische Verwendung
DE1443412C (cg-RX-API-DMAC10.html)
DE1206907B (de) Verfahren zur Herstellung von N-Glykosiden
DE2529533A1 (de) 3-desazaguanin sowie derivate dieser verbindung
DE1445471C (de) Verfahren zur Herstellung von 5' Nucleotiden

Legal Events

Date Code Title Description
D2 Grant after examination
8364 No opposition during term of opposition